{{Rsnum
|rsid=1143639
|Gene=IL1B
|Chromosome=2
|position=112831216
|Orientation=minus
|GMAF=0.1451
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL1B
}}{{PharmGKB
|RSID=rs1143639
|Name_s=
|Gene_s=IL1B
|Feature=Intron
|Evidence=PubMed ID:19431193
|Annotation=This variant in the IL1B gene was associated with lung disease severity categories (P < 0.10) and longitudinal analysis of lung disease severity (P < 0.10) in a study of 808 cystic fibrosis patients, suggesting IL1B may be a clinically relevant modulator of CF lung disease.
|Drugs=
|Drug Classes=
|Diseases=Cystic Fibrosis; Lung Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA164856839
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1143639
|overall_frequency_n=17
|overall_frequency_d=128
|overall_frequency=0.132812
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}